Astellas, UCB Introduce Rheumatoid Arthritis Therapy in Japan

Astellas Pharma and UCB have introduced Cimzia rheumatoid arthritis therapy in Japan. The PEGylated Fc-free anti-TNF medication is indicated for adult rheumatoid arthritis patients who showed poor response to conservative treatment.
Pharmaceutical Business Review